medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

1999, Number 5

<< Back Next >>

Alerg Asma Inmunol Pediatr 1999; 8 (5)

Evidence based on the treatment of bronchial asthma

Hernández CD

Language: Spanish
References: 21
Page: 131-134
PDF size: 244.43 Kb.


ABSTRACT

Many studies during the past 40 years have shown statistically and clinically significant dose-dependent benefit with allergen immunotherapy. Most, however, focused on patients with allergic rhinitis because asthma is more multifactorial. Consequently, controversy has existed on the utility of allergen immunotherapy in asthma management. Recent studies show that immunotherapy can inhibit latephase response and may work through induction of T-cell tolerance; in contrast to medication that affects only symptoms, immunotherapy can favorably affect the disease process that inderlies asthma symptoms.


REFERENCES

  1. Global Strategy fot asthma management and prevention NHLBI/WHO Workshop Report. National Institutes of Health. Publication Number 95-3659. 1995

  2. National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. US Department of Health and Human Services, publication No. 97-4051. Bethesda: National Institutes of Health 1997.

  3. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862-866.

  4. Vergara Hoehenstein R. Proyecto Nacional de Asma Instituto Mexicano del Seguro Social 1999.

  5. Storms B, Olden L, Nathan R, Bodman S. Effect of allergy specialist care on the quality of the life in patients with asthma. Ann Allergy Asthma Immunol 1995; 75: 491-494.

  6. Busse WW. Inflammation in asthma: The cornerstone of the disease and taget of therapy. J Allergy Clin Immunol 1998; 102: SI7-S22.

  7. Abramson MJ, Puy RM, Winer JM. Allergen immunotherapy effective in asthma? A metaanalysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-974.

  8. Bousquet J, Michel F-B. Specific immunotherapy in asthma: Is it effective? J Allergy Clin Immunol 1994; 94: 1-11.

  9. Expert Care and Immunotherapy for asthma. ACAAI 1996.

  10. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Eng J Med 1992; 326: 862-866.

  11. Stanley J, Szefler, Nelson H. Altern, 102 active agents for anti-inflammatory treatment of asthma. J Allergy Clin Immunol 1998; 102: 523-S35.

  12. Mahr TA, Evans R. Allergist influence on asthma care. Ann Allergy 1993; 71: 115120.

  13. Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services. Expert panel report Publication No. 91-3042. 1991: 67.

  14. Zeiger RS et al. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Alergy Clin Immunol 1991; 87: 1160-1168.

  15. Hanvey L, Avard D, Graham I et al. The Health of Canada’s Children: A CICH Profile. ed. Ottava Canadian Institute of Child Health 1994.

  16. Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 1994; 93: 205-10.

  17. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the ED treatment of children with acute asthma. Pediatrics 1993; 92: 695-6.

  18. Platts-Mills TA. Am Rev Respir Dis 1993; 148: 553-5.

  19. Varney VA, Hamid QA, Gaga M et al. J Clin Invest 1993; 92: 644-5.

  20. Creticos PS, Reed CE, Norman PS. Subcenter Investigators of the NIAID Study et al. J Allergy Clin Immunol 1993; 91: 227.

  21. Stewart GE 2d, Lockey RF. J Allergy Clin Immunol 1992; 90: 567-78.




2020     |     www.medigraphic.com